Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472121 - 472140 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 3MG TAB | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 3MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 3MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 3MG TAB | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 4MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 4MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 4MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 4MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 13.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 13.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 4.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 4.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 9MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 9MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN04) futibatinib | LYTGOBI 4MG X 3 (12MG) DAILY PKT,21 | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TaihoOncology,Inc. |
| USA | (L01EN04) futibatinib | LYTGOBI 4MG X 4 (16MG) DAILY PKT,28 | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TaihoOncology,Inc. |
| USA | (L01EN04) futibatinib | LYTGOBI 4MG X 5 (20MG) DAILY PKT,35 | 35 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TaihoOncology,Inc. |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
Pages
